428 related articles for article (PubMed ID: 23086101)
1. The new oral anticoagulants: a challenge for hospital formularies.
Merli GJ
Hosp Pract (1995); 2012 Aug; 40(3):126-8. PubMed ID: 23086101
[TBL] [Abstract][Full Text] [Related]
2. Novel oral anticoagulants: a review of the literature and considerations in special clinical situations.
Akwaa F; Spyropoulos AC
Hosp Pract (1995); 2013 Feb; 41(1):8-18. PubMed ID: 23466963
[TBL] [Abstract][Full Text] [Related]
3. Importance of pharmacokinetic profile and variability as determinants of dose and response to dabigatran, rivaroxaban, and apixaban.
Gong IY; Kim RB
Can J Cardiol; 2013 Jul; 29(7 Suppl):S24-33. PubMed ID: 23790595
[TBL] [Abstract][Full Text] [Related]
4. Direct oral anticoagulants in the prevention of venous thromboembolism: evidence from major clinical trials.
Prandoni P; Temraz S; Taher A
Semin Hematol; 2014 Apr; 51(2):121-30. PubMed ID: 24861796
[TBL] [Abstract][Full Text] [Related]
5. Emerging oral anticoagulants for stroke prevention in patients with non-valvular atrial fibrillation.
Destephan C; Waller AH; Patel RJ; Dhruvakumar S; Mazza V; Gerula C; Maher J; Kaluski E
Minerva Cardioangiol; 2012 Aug; 60(4):425-31. PubMed ID: 22858920
[TBL] [Abstract][Full Text] [Related]
6. Perioperative management of patients on new oral anticoagulants.
Lai A; Davidson N; Galloway SW; Thachil J
Br J Surg; 2014 Jun; 101(7):742-9. PubMed ID: 24777590
[TBL] [Abstract][Full Text] [Related]
7. Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation.
Berman JP; Halperin JL
Hosp Pract (1995); 2013 Feb; 41(1):37-48. PubMed ID: 23466966
[TBL] [Abstract][Full Text] [Related]
8. A new era of oral anticoagulation in atrial fibrillation: implications in clinical practice.
Kasmeridis C; Lip GY; Apostolakis S
Hosp Pract (1995); 2013 Feb; 41(1):61-70. PubMed ID: 23466968
[TBL] [Abstract][Full Text] [Related]
9. Novel oral anticoagulants for thromboprophylaxis after orthopaedic surgery.
Quinlan DJ; Eriksson BI
Best Pract Res Clin Haematol; 2013 Jun; 26(2):171-82. PubMed ID: 23953905
[TBL] [Abstract][Full Text] [Related]
10. Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation: dawn of a new era.
Contractor T; Levin V; Martinez MW; Marchlinski FE
Postgrad Med; 2013 Jan; 125(1):34-44. PubMed ID: 23391669
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and pharmacodynamic drug interactions with new oral anticoagulants: what do they mean for patients with atrial fibrillation?
Hellwig T; Gulseth M
Ann Pharmacother; 2013 Nov; 47(11):1478-87. PubMed ID: 24259602
[TBL] [Abstract][Full Text] [Related]
12. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
[TBL] [Abstract][Full Text] [Related]
13. New oral anticoagulants: will they replace warfarin?
Little JW
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 May; 113(5):575-80. PubMed ID: 22668618
[TBL] [Abstract][Full Text] [Related]
14. The new oral anticoagulants in clinical practice.
Gonsalves WI; Pruthi RK; Patnaik MM
Mayo Clin Proc; 2013 May; 88(5):495-511. PubMed ID: 23639500
[TBL] [Abstract][Full Text] [Related]
15. [Evidence of novel oral anticoagulants (NOAC)].
Kitazono T
Rinsho Shinkeigaku; 2013; 53(11):992-3. PubMed ID: 24291856
[TBL] [Abstract][Full Text] [Related]
16. [Clinical pharmacological aspects of new oral anticoagulants].
Haschke M
Ther Umsch; 2012 Nov; 69(11):657-60. PubMed ID: 23117669
[TBL] [Abstract][Full Text] [Related]
17. Disadvantages of VKA and requirements for novel anticoagulants.
Shameem R; Ansell J
Best Pract Res Clin Haematol; 2013 Jun; 26(2):103-14. PubMed ID: 23953899
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience with novel oral anticoagulants for thromboprophylaxis after elective hip and knee arthroplasty.
Messerschmidt C; Friedman RJ
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):771-8. PubMed ID: 25767271
[TBL] [Abstract][Full Text] [Related]
19. New oral anticoagulants vs. warfarin treatment: no need for pharmacogenomics?
Baker WL; Chamberlin KW
Clin Pharmacol Ther; 2014 Jul; 96(1):17-9. PubMed ID: 24942397
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in antithrombotic therapy for stroke prevention in patients with atrial fibrillation.
Lenchus JD
Hosp Pract (1995); 2013 Feb; 41(1):49-60. PubMed ID: 23466967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]